Medical device cybersecurity
Medical device cybersecurity requirements are landing on Energy, Power & Commodities operators faster than most compliance teams anticipated, driven by the U.S. Food and Drug Administration's 2023 cyber device guidance and parallel scrutiny from the U.S. Department of Energy and the European Union Agency for Cybersecurity over networked diagnostic and monitoring equipment embedded in grid and plant infrastructure. The FDA's authority under Section 524B of the FD&C Act now compels manufacturers to submit software bills of materials and coordinated vulnerability disclosure plans, and energy-sector buyers of that equipment inherit the downstream compliance exposure. Cresthaven is actively monitoring this intersection for enforcement signals, new guidance, and cross-border requirements as they materialize.
Watch
- FDA Section 524B premarket cyber submissions affecting grid-connected medical monitoring vendors
- EU Cyber Resilience Act device classification rules: deadlines begin phasing in 2025
- DOE grid security orders referencing networked biomedical equipment in critical facilities
- Vendor contract liability gaps as software bill of materials requirements take effect
- APAC: Japan's PMDA cybersecurity guidance expanding to industrial-use medical devices
Recent material activity in Energy, Power & Commodities
Active monitoring in place across Energy, Power & Commodities. Material developments related to medical device cybersecurity will appear here as they are published.